165 related articles for article (PubMed ID: 35240973)
1. Modifications of Ribonucleases in Order to Enhance Cytotoxicity in Anticancer Therapy.
Nassiri M; Gopalan V; Vakili-Azghandi M
Curr Cancer Drug Targets; 2022; 22(5):373-387. PubMed ID: 35240973
[TBL] [Abstract][Full Text] [Related]
2. Antibody-targeted RNase fusion proteins (immunoRNases) for cancer therapy.
Krauss J; Arndt MA; Dübel S; Rybak SM
Curr Pharm Biotechnol; 2008 Jun; 9(3):231-4. PubMed ID: 18673289
[TBL] [Abstract][Full Text] [Related]
3. Refined immunoRNases for the efficient targeting and selective killing of tumour cells: A novel strategy.
Nassiri M; Behnam-Rasouli R; Vakili-Azghandi M; Gopalan V; Dolati P; Nourmohammadi R
Life Sci; 2022 Jan; 289():120222. PubMed ID: 34902436
[TBL] [Abstract][Full Text] [Related]
4. Biological Activities of Secretory RNases: Focus on Their Oligomerization to Design Antitumor Drugs.
Gotte G; Menegazzi M
Front Immunol; 2019; 10():2626. PubMed ID: 31849926
[TBL] [Abstract][Full Text] [Related]
5. Ribonucleases as potential modalities in anticancer therapy.
Ardelt W; Ardelt B; Darzynkiewicz Z
Eur J Pharmacol; 2009 Dec; 625(1-3):181-9. PubMed ID: 19825371
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic ribonucleases and chimeras in cancer therapy.
Youle RJ; Newton D; Wu YN; Gadina M; Rybak SM
Crit Rev Ther Drug Carrier Syst; 1993; 10(1):1-28. PubMed ID: 8472310
[TBL] [Abstract][Full Text] [Related]
7. Ribonucleases and immunoRNases as anticancer drugs.
Rybak SM; Arndt MA; Schirrmann T; Dübel S; Krauss J
Curr Pharm Des; 2009; 15(23):2665-75. PubMed ID: 19689337
[TBL] [Abstract][Full Text] [Related]
8. [Cellular targets of antitumor ribonucleases].
Mit'kevich VA; Makarov AA; Il'inskaia ON
Mol Biol (Mosk); 2014; 48(2):214-22. PubMed ID: 25850290
[TBL] [Abstract][Full Text] [Related]
9. Targeted therapeutic RNases (ImmunoRNases).
Schirrmann T; Krauss J; Arndt MA; Rybak SM; Dübel S
Expert Opin Biol Ther; 2009 Jan; 9(1):79-95. PubMed ID: 19063695
[TBL] [Abstract][Full Text] [Related]
10. Microbial ribonucleases (RNases): production and application potential.
Hameş EE; Demir T
World J Microbiol Biotechnol; 2015 Dec; 31(12):1853-62. PubMed ID: 26433394
[TBL] [Abstract][Full Text] [Related]
11. On the track of antitumour ribonucleases.
Benito A; Ribó M; Vilanova M
Mol Biosyst; 2005 Oct; 1(4):294-302. PubMed ID: 16880994
[TBL] [Abstract][Full Text] [Related]
12. [Trends in the pharmaceutical research of ribonucleases and their therapeutic uses].
Zhang Y; Li W; Su Z
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2001 Sep; 18(3):456-60. PubMed ID: 11605516
[TBL] [Abstract][Full Text] [Related]
13. [Why ribonucleases cause death of cancer cells].
Il'inskaia ON; Makarov AA
Mol Biol (Mosk); 2005; 39(1):3-13. PubMed ID: 15773542
[TBL] [Abstract][Full Text] [Related]
14. Binase and other microbial RNases as potential anticancer agents.
Makarov AA; Kolchinsky A; Ilinskaya ON
Bioessays; 2008 Aug; 30(8):781-90. PubMed ID: 18623073
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity and toxicity of anti-HER2 immunoRNase scFv 4D5-dibarnase in mice bearing human breast cancer xenografts.
Balandin TG; Edelweiss E; Andronova NV; Treshalina EM; Sapozhnikov AM; Deyev SM
Invest New Drugs; 2011 Feb; 29(1):22-32. PubMed ID: 19789841
[TBL] [Abstract][Full Text] [Related]
16. Antibody fusion proteins with human ribonucleases 1 to 8.
Wezler X; Dübel S; Schirrmann T
Hum Antibodies; 2018; 26(4):177-192. PubMed ID: 29689715
[TBL] [Abstract][Full Text] [Related]
17. [Ribonucleases as antiviral agents].
Il'inskaia ON; Shakh Makhmud R
Mol Biol (Mosk); 2014; 48(5):707-17. PubMed ID: 25842855
[TBL] [Abstract][Full Text] [Related]
18. Natural and engineered ribonucleases as potential cancer therapeutics.
Arnold U; Ulbrich-Hofmann R
Biotechnol Lett; 2006 Oct; 28(20):1615-22. PubMed ID: 16902846
[TBL] [Abstract][Full Text] [Related]
19. Ribonucleases as a novel pro-apoptotic anticancer strategy: review of the preclinical and clinical data for ranpirnase.
Costanzi J; Sidransky D; Navon A; Goldsweig H
Cancer Invest; 2005; 23(7):643-50. PubMed ID: 16305992
[TBL] [Abstract][Full Text] [Related]
20. [Onconase: a ribonuclease with antitumor activity].
Zwolińska M; Smolewski P
Postepy Hig Med Dosw (Online); 2010 Feb; 64():58-66. PubMed ID: 20173221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
